Distribution of hepatitis B virus genotypes in HIV-infected patients with chronic hepatitis B: therapeutic implications.

Hepatitis B virus (HBV) genotypes were examined in HIV-infected patients with chronic HBV infection seen in our clinic during 2002. A total of 28 of 1100 individuals (prevalence 2.5%) were found to be HBsAg and HBV-DNA positive. HBV genotypes could be determined in 23 of them. HBV-A was the most common (57%), followed by HBV-D (39%). HBV-A predominated among homosexual men (67%) while HBV-D predominated among intravenous drug users (67%). The presence of serum HBeAg was significantly associated with the HBV-A genotype.

[1]  Makoto Arai,et al.  Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease , 2003, Hepatology.

[2]  B. Gazzard,et al.  An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals , 2003, AIDS.

[3]  P. Tebas,et al.  Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed. , 2002, The Journal of infectious diseases.

[4]  P. Marcellin,et al.  Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. , 2002, Gastroenterology.

[5]  V. Soriano,et al.  Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine. , 2002, AIDS.

[6]  J. Phair,et al.  HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) , 2002, The Lancet.

[7]  R. Bruno,et al.  Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. , 2002, AIDS reviews.

[8]  D. Vassilopoulos,et al.  Hepatitis B e antigen–negative chronic hepatitis B , 2001, Hepatology.

[9]  A. Lok,et al.  Management of hepatitis B: 2000--summary of a workshop. , 2001, Gastroenterology.

[10]  J. Petersen,et al.  20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw , 2001, The Lancet.

[11]  Ding‐Shinn Chen,et al.  Hepatitis B genotypes and the response to interferon therapy. , 2000, Journal of hepatology.

[12]  Ding‐Shinn Chen,et al.  Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. , 2000, Gastroenterology.

[13]  K. Kidd‐Ljunggren,et al.  Genotypic differences in the hepatitis B virus core promoter and precore sequences during seroconversion from HBeAg to anti‐HBe , 2000, Journal of medical virology.

[14]  R F Schinazi,et al.  A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. , 2000, The Journal of general virology.

[15]  C. Katlama,et al.  Long‐term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus–infected patients , 1999, Hepatology.

[16]  S. Wirth,et al.  The hepatitis B virus seroconversion to anti-HBe is frequently associated with HBV genotype changes and selection of preS2-defective particles in chronically infected children. , 1998, Virology.

[17]  M Lindh,et al.  Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method. , 1997, The Journal of infectious diseases.

[18]  A. Couroucé,et al.  Complete nucleotide sequences of six hepatitis B viral genomes encoding the surface antigen subtypes ayw4, adw4q-, and adrq- and their phylogenetic classification. , 1993, Archives of virology. Supplementum.

[19]  H. Sakugawa,et al.  Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. , 1988, The Journal of general virology.